Seroba Life Sciences logo

Seroba Life Sciences

Europe, Dublin, Ireland, Dublin

Description

Seroba is a life sciences venture capital firm, focused on investing in breakthrough healthcare technologies.

Investor Profile

Seroba Life Sciences has made 45 investments, with 6 in the past 12 months and 36% as lead.

Stage Focus

  • Series A (36%)
  • Series B (33%)
  • Series Unknown (18%)
  • Series D (4%)
  • Series C (4%)
  • Private Equity (2%)
  • Seed (2%)

Country Focus

  • Ireland (36%)
  • United Kingdom (27%)
  • United States (13%)
  • Switzerland (7%)
  • France (4%)
  • The Netherlands (4%)
  • Canada (4%)
  • Spain (2%)
  • Italy (2%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Medical Device
  • Therapeutics
  • Pharmaceutical
  • Manufacturing
  • Clinical Trials
  • Biopharma
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Seroba Life Sciences frequently co-invest with?

Wellington Partners
Europe, Bayern, Germany, Munich
Co-Investments: 4
Omnes Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 3
Act Venture Capital
Europe, Dublin, Ireland, Dublin
Co-Investments: 3
Atlantic Bridge
Europe, Dublin, Ireland, Dublin
Co-Investments: 4
b2venture
Europe, Berlin, Germany, Berlin
Co-Investments: 4
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 5
Enterprise Ireland
Europe, Dublin, Ireland, Dublin
Co-Investments: 8
Kurma Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 4
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 6
Inventages Venture Capital Investment Inc.
Europe, England, United Kingdom, London
Co-Investments: 4

Which angels does Seroba Life Sciences often collaborate with?

Shared Deals: 1

What are some of recent deals done by Seroba Life Sciences?

Perfuze

Newcastle, Galway, Ireland

Perfuze is a medical device company developing catheter-based aspiration technology to treat acute ischemic stroke.

Health CareManufacturingMedicalMedical Device
Series UnknownMar 13, 2025
Amount Raised: $23,936,512
Coave Therapeutics

Paris, Ile-de-France, France

Horama develops gene therapies for rare inherited ocular and CNS (central nervous system) diseases.

BiotechnologyGeneticsLife ScienceNeuroscience
Series AJan 9, 2025
Amount Raised: $32,948,556
Deciphex

Glasnevin, Dublin, Ireland

Deciphex builds a network of AI empowered pathologists ensuring accessible pathology services that improves patient outcomes.

Artificial Intelligence (AI)Health DiagnosticsSoftware
Series CJan 7, 2025
Amount Raised: $32,202,774
ShiraTronics

Minneapolis, Minnesota, United States

ShiraTronics develops neuromodulation technology to combat debilitating chronic migraine.

Clinical TrialsHealth CareMedical Device
Series BSep 30, 2024
Amount Raised: $66,000,000
Loci Orthopaedics

Galway, Galway, Ireland

A innovative orthopaedic implant for the treatment of thumb base arthritis.

BiotechnologyLife ScienceMedical Device
Series AJul 17, 2024
Amount Raised: $13,959,580
Vico Therapeutics

Leiden, Zuid-Holland, The Netherlands

Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies.

Health CareMedicalPharmaceutical
Series BJun 24, 2024
Amount Raised: $12,298,137
Artica Therapeutics

Leiden, Zuid-Holland, The Netherlands

Artica Therapeutics specializes in biotechnological research and development for medical devices, pharmaceutical processes, and food.

Biotechnology
SeedNov 3, 2023
Amount Raised: $12,883,139
Shorla Pharma

Clonmel, Tipperary, Ireland

Shorla Pharma is an Irish specialty pharmaceutical company.

BiotechnologyPharmaceutical
Series BOct 4, 2023
Amount Raised: $35,000,000
Complement Therapeutics

London, England, United Kingdom

Complement Therapeutics operates as a preclinical stage company.

BiotechnologyMedical
Series AApr 17, 2023
Amount Raised: $78,657,148
Storm Therapeutics

Cambridge, Cambridgeshire, United Kingdom

Targeting pathways that modify RNA to deliver novel cancer therapeutics

BiotechnologyHealth CareMedicalTherapeutics
Series BDec 14, 2022
Amount Raised: $30,000,000